Clinical Trial Update: SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated vorinostat (SAHA) in combination with CHOP chemotherapy in patients with untreated T-cell non-Hodgkin's lymphoma; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)
• Vorinostat (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-09